Crestchem Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 15, 2025, 11:00 am

Market Cap	39.6 Cr.
Current Price	132
High / Low	350/114
Stock P/E	16.0
Book Value	24.9
Dividend Yield	0.76 %
ROCE	59.9 %
ROE	44.1 %
Face Value	10.0
PEG Ratio	0.47

Quick Insight

Crestchem Ltd, a player in the organic chemicals segment, currently trades at ₹132 with a market capitalization of ₹39.6 Cr and a P/E ratio of 16.0. The company boasts a robust Return on Equity (ROE) of 44.1% and Return on Capital Employed (ROCE) of 59.9%, well above industry averages. With a healthy Operating Profit Margin (OPM) of 7.16% and an Interest Coverage Ratio (ICR) of 271.82x, Crestchem demonstrates strong operational efficiency and financial stability. Moreover, its debt-free status, high promoter holding at 29.43%, and consistent net profit of ₹2.73 Cr indicate a solid financial foundation.

However, Crestchem faces risks from its high Price-to-Book Value (P/BV) ratio of 8.29x, suggesting the stock may be overvalued compared to industry peers. Additionally, the company's Cash Conversion Cycle (CCC) of 37.41 days may indicate inefficiencies in working capital management that could impact liquidity. Looking ahead, Crestchem's growth prospects hinge on its ability to sustain profitability amidst volatile raw material prices and evolving regulatory landscapes in the chemicals sector. If the company can enhance operational efficiency further and diversify its product portfolio to mitigate risks, it may attract more investor interest and drive stock price appreciation.

In conclusion, while Crestchem exhibits strong financial metrics and a solid market position, investors should closely monitor its valuation levels and operational performance. By staying attuned to industry trends and the company's strategic initiatives, investors can make informed decisions regarding Crestchem's stock as part of a well-diversified portfolio.

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Crestchem Ltd

Competitors of Crestchem Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Gujchem Distillers India Ltd	141 Cr.	394	541/255	145	390	0.02 %	0.22 %	0.10 %	1.00
Elantas Beck India Ltd	8,284 Cr.	10,450	14,980/8,150	62.3	1,177	0.07 %	23.0 %	17.4 %	10.0
Crestchem Ltd	39.6 Cr.	132	350/114	16.0	24.9	0.76 %	59.9 %	44.1 %	10.0
Chemiesynth (Vapi) Ltd	11.0 Cr.	35.8	35.8/0.00		35.8	0.00 %	3.10 %	0.99 %	10.0
Archit Organosys Ltd	94.1 Cr.	45.9	53.5/34.2	15.4	33.7	1.09 %	10.8 %	7.62 %	10.0
Industry Average	5,051.77 Cr	1,870.88		58.19	341.08	0.37%	14.38%	10.48%	7.41

All Competitor Stocks of Crestchem Ltd

Quarterly Result

Metric	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Sales	4.80	3.89	5.17	2.87	3.78	4.49	7.36	5.63	5.25	7.80	4.80	7.23	5.03
Expenses	4.63	3.74	4.71	2.83	3.51	4.08	6.13	4.78	4.49	6.53	4.15	6.63	4.67
Operating Profit	0.17	0.15	0.46	0.04	0.27	0.41	1.23	0.85	0.76	1.27	0.65	0.60	0.36
OPM %	3.54%	3.86%	8.90%	1.39%	7.14%	9.13%	16.71%	15.10%	14.48%	16.28%	13.54%	8.30%	7.16%
Other Income	0.03	0.03	0.03	0.05	0.05	0.06	0.06	0.09	0.08	0.12	0.09	0.14	0.13
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.01	0.01	0.01	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.02	0.02
Profit before tax	0.20	0.17	0.48	0.08	0.32	0.46	1.28	0.93	0.83	1.38	0.73	0.72	0.47
Tax %	25.00%	23.53%	27.08%	12.50%	25.00%	26.09%	28.91%	27.96%	27.71%	28.26%	27.40%	15.28%	25.53%
Net Profit	0.14	0.12	0.36	0.07	0.24	0.34	0.91	0.66	0.60	1.00	0.52	0.61	0.35
EPS in Rs	0.47	0.40	1.20	0.23	0.80	1.13	3.03	2.20	2.00	3.33	1.73	2.03	1.17

Last Updated: August 19, 2025, 8:35 pm

Below is a detailed analysis of the quarterly data for Crestchem Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

For Sales, as of Jun 2025, the value is 5.03 Cr.. The value appears to be declining and may need further review. It has decreased from 7.23 Cr. (Mar 2025) to 5.03 Cr., marking a decrease of 2.20 Cr..
For Expenses, as of Jun 2025, the value is 4.67 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 6.63 Cr. (Mar 2025) to 4.67 Cr., marking a decrease of 1.96 Cr..
For Operating Profit, as of Jun 2025, the value is 0.36 Cr.. The value appears to be declining and may need further review. It has decreased from 0.60 Cr. (Mar 2025) to 0.36 Cr., marking a decrease of 0.24 Cr..
For OPM %, as of Jun 2025, the value is 7.16%. The value appears to be declining and may need further review. It has decreased from 8.30% (Mar 2025) to 7.16%, marking a decrease of 1.14%.
For Other Income, as of Jun 2025, the value is 0.13 Cr.. The value appears to be declining and may need further review. It has decreased from 0.14 Cr. (Mar 2025) to 0.13 Cr., marking a decrease of 0.01 Cr..
For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
For Depreciation, as of Jun 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.02 Cr..
For Profit before tax, as of Jun 2025, the value is 0.47 Cr.. The value appears to be declining and may need further review. It has decreased from 0.72 Cr. (Mar 2025) to 0.47 Cr., marking a decrease of 0.25 Cr..
For Tax %, as of Jun 2025, the value is 25.53%. The value appears to be increasing, which may not be favorable. It has increased from 15.28% (Mar 2025) to 25.53%, marking an increase of 10.25%.
For Net Profit, as of Jun 2025, the value is 0.35 Cr.. The value appears to be declining and may need further review. It has decreased from 0.61 Cr. (Mar 2025) to 0.35 Cr., marking a decrease of 0.26 Cr..
For EPS in Rs, as of Jun 2025, the value is 1.17. The value appears to be declining and may need further review. It has decreased from 2.03 (Mar 2025) to 1.17, marking a decrease of 0.86.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 8:03 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	0.42	0.09	0.13	0.14	0.05	0.10	6.15	7.62	7.90	16.66	21.18	24.98	24.86
Expenses	0.36	0.23	0.18	0.34	0.29	0.26	5.59	6.95	7.15	15.84	18.40	21.66	21.98
Operating Profit	0.06	-0.14	-0.05	-0.20	-0.24	-0.16	0.56	0.67	0.75	0.82	2.78	3.32	2.88
OPM %	14.29%	-155.56%	-38.46%	-142.86%	-480.00%	-160.00%	9.11%	8.79%	9.49%	4.92%	13.13%	13.29%	11.58%
Other Income	0.03	0.89	0.19	0.08	0.03	0.02	0.03	0.05	0.08	0.15	0.26	0.44	0.48
Interest	0.03	0.02	0.02	0.04	0.01	0.01	0.00	0.02	0.02	0.01	0.01	0.05	0.00
Depreciation	0.08	0.05	0.00	0.00	0.00	0.01	0.02	0.02	0.03	0.02	0.05	0.05	0.06
Profit before tax	-0.02	0.68	0.12	-0.16	-0.22	-0.16	0.57	0.68	0.78	0.94	2.98	3.66	3.30
Tax %	0.00%	10.29%	25.00%	0.00%	-13.64%	0.00%	22.81%	14.71%	26.92%	26.60%	27.85%	25.41%
Net Profit	-0.03	0.61	0.09	-0.16	-0.19	-0.17	0.44	0.57	0.57	0.69	2.15	2.73	2.48
EPS in Rs	-0.10	2.03	0.30	-0.53	-0.63	-0.57	1.47	1.90	1.90	2.30	7.17	9.10	8.26
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	6.98%	10.99%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	2133.33%	-85.25%	-277.78%	-18.75%	10.53%	358.82%	29.55%	0.00%	21.05%	211.59%	26.98%
Change in YoY Net Profit Growth (%)	0.00%	-2218.58%	-192.53%	259.03%	29.28%	348.30%	-329.28%	-29.55%	21.05%	190.54%	-184.62%

Crestchem Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	76%
5 Years:	32%
3 Years:	47%
TTM:	9%

Compounded Profit Growth
10 Years:	34%
5 Years:	44%
3 Years:	69%
TTM:	-1%

Stock Price CAGR
10 Years:	28%
5 Years:	43%
3 Years:	42%
1 Year:	-26%

Return on Equity
10 Years:	35%
5 Years:	44%
3 Years:	45%
Last Year:	44%

Last Updated: September 5, 2025, 3:06 pm

Balance Sheet

Last Updated: August 11, 2025, 3:43 pm

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00
Reserves	-2.59	-2.09	-2.00	-2.16	-2.36	-2.53	-2.08	-1.51	-0.94	-0.25	1.90	4.48
Borrowings	0.40	0.37	0.35	0.60	0.14	0.28	0.02	0.63	0.27	0.00	0.00	0.00
Other Liabilities	0.49	0.22	0.05	0.05	0.04	0.14	1.35	0.87	0.96	2.04	2.24	3.07
Total Liabilities	1.30	1.50	1.40	1.49	0.82	0.89	2.29	2.99	3.29	4.79	7.14	10.55
Fixed Assets	0.46	0.04	0.04	0.04	0.11	0.12	0.10	0.14	0.11	0.10	0.17	0.26
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	0.84	1.46	1.36	1.45	0.71	0.77	2.19	2.85	3.18	4.69	6.97	10.29
Total Assets	1.30	1.50	1.40	1.49	0.82	0.89	2.29	2.99	3.29	4.79	7.14	10.55

Below is a detailed analysis of the balance sheet data for Crestchem Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 3.00 Cr..
For Reserves, as of Mar 2025, the value is 4.48 Cr.. The value appears strong and on an upward trend. It has increased from 1.90 Cr. (Mar 2024) to 4.48 Cr., marking an increase of 2.58 Cr..
For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Other Liabilities, as of Mar 2025, the value is 3.07 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.24 Cr. (Mar 2024) to 3.07 Cr., marking an increase of 0.83 Cr..
For Total Liabilities, as of Mar 2025, the value is 10.55 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.14 Cr. (Mar 2024) to 10.55 Cr., marking an increase of 3.41 Cr..
For Fixed Assets, as of Mar 2025, the value is 0.26 Cr.. The value appears strong and on an upward trend. It has increased from 0.17 Cr. (Mar 2024) to 0.26 Cr., marking an increase of 0.09 Cr..
For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Other Assets, as of Mar 2025, the value is 10.29 Cr.. The value appears strong and on an upward trend. It has increased from 6.97 Cr. (Mar 2024) to 10.29 Cr., marking an increase of 3.32 Cr..
For Total Assets, as of Mar 2025, the value is 10.55 Cr.. The value appears strong and on an upward trend. It has increased from 7.14 Cr. (Mar 2024) to 10.55 Cr., marking an increase of 3.41 Cr..

Notably, the Reserves (4.48 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	-0.10	0.05	-0.27	-0.04	-0.70	-0.02	0.33	0.39	0.82	2.21	0.35	1.66
Cash from Investing Activity +	0.02	0.06	0.34	0.64	0.12	0.01	-0.35	-0.39	-0.83	-1.34	-1.07	-0.99
Cash from Financing Activity +	0.07	-0.05	-0.02	-0.04	-0.01	-0.01	0.00	-0.02	-0.02	-0.01	-0.01	-0.09
Net Cash Flow	-0.01	0.06	0.05	0.55	-0.58	-0.02	-0.02	-0.01	-0.02	0.86	-0.72	0.59

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-0.34	-0.51	-0.40	-0.80	-0.38	-0.44	0.54	0.04	0.48	0.82	2.78	3.32

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	356.31	0.00	336.92	469.29	730.00	292.00	71.81	67.54	41.58	0.44	26.37	37.41
Inventory Days	0.00	60.83	0.00	73.00	0.00	182.50	0.75	0.00	0.00	0.00	0.00	0.00
Days Payable		60.83		73.00		365.00	91.06
Cash Conversion Cycle	356.31	0.00	336.92	469.29	730.00	109.50	-18.50	67.54	41.58	0.44	26.37	37.41
Working Capital Days	-234.64	-1,987.22	-645.77	-1,016.79	438.00	-292.00	3.56	12.93	-2.77	-36.81	-1.21	8.47
ROCE %	1.30%	-13.40%	10.65%	-8.60%	-18.92%	-19.61%	67.46%	45.75%	35.96%	37.40%	78.17%	59.94%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Promoters	31.87%	31.95%	31.45%	31.65%	31.92%	32.09%	32.11%	32.05%	32.04%	32.12%	32.21%	29.43%
DIIs	0.13%	0.13%	0.13%	0.13%	0.13%	0.13%	0.13%	0.13%	0.13%	0.13%	0.13%	0.13%
Public	68.00%	67.92%	68.43%	68.22%	67.95%	67.78%	67.75%	67.82%	67.83%	67.77%	67.66%	70.45%
No. of Shareholders	94	11,386	11,442	11,450	11,461	11,510	11,456	11,931	12,423	12,966	12,886	12,843

Shareholding Pattern Chart

No. of Shareholders

Crestchem Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	9.09	7.15	2.31	1.89	19.91
Diluted EPS (Rs.)	9.09	7.15	2.31	1.89	19.91
Cash EPS (Rs.)	9.26	7.31	2.39	1.98	1.99
Book Value[Excl.RevalReserv]/Share (Rs.)	24.92	16.33	9.18	6.87	4.97
Book Value[Incl.RevalReserv]/Share (Rs.)	24.92	16.33	9.18	6.87	4.97
Dividend / Share (Rs.)	1.00	0.50	0.00	0.00	0.00
Revenue From Operations / Share (Rs.)	83.59	70.85	55.76	26.49	25.47
PBDIT / Share (Rs.)	12.41	10.11	3.23	2.74	2.38
PBIT / Share (Rs.)	12.23	9.96	3.16	2.66	2.30
PBT / Share (Rs.)	12.19	9.93	3.13	2.60	2.24
Net Profit / Share (Rs.)	9.09	7.15	2.31	1.89	1.91
PBDIT Margin (%)	14.84	14.27	5.80	10.35	9.33
PBIT Margin (%)	14.63	14.05	5.66	10.02	9.02
PBT Margin (%)	14.58	14.01	5.60	9.82	8.81
Net Profit Margin (%)	10.87	10.09	4.14	7.13	7.51
Return on Networth / Equity (%)	36.46	43.80	25.18	27.53	38.46
Return on Capital Employeed (%)	48.63	60.53	34.26	38.57	44.70
Return On Assets (%)	25.85	30.04	14.48	17.22	19.14
Total Debt / Equity (X)	0.00	0.00	0.00	0.12	0.42
Asset Turnover Ratio (%)	2.84	3.56	4.14	2.53	2.89
Current Ratio (X)	1.44	1.04	0.60	0.95	1.85
Quick Ratio (X)	1.44	1.04	0.60	0.95	1.85
Inventory Turnover Ratio (X)	0.00	0.00	11553.39	2181.02	1235.35
Interest Coverage Ratio (X)	271.82	430.21	98.75	52.20	44.41
Interest Coverage Ratio (Post Tax) (X)	200.07	305.40	71.56	36.98	36.75
Enterprise Value (Cr.)	61.25	34.07	35.86	12.56	7.51
EV / Net Operating Revenue (X)	2.44	1.60	2.14	1.58	0.98
EV / EBITDA (X)	16.45	11.23	36.95	15.26	10.53
MarketCap / Net Operating Revenue (X)	2.47	1.61	2.20	1.55	1.03
Price / BV (X)	8.29	6.98	13.34	5.97	5.27
Price / Net Operating Revenue (X)	2.47	1.61	2.20	1.55	1.03
EarningsYield	0.04	0.06	0.01	0.04	0.07

After reviewing the key financial ratios for Crestchem Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 25, the value is 9.09. This value is within the healthy range. It has increased from 7.15 (Mar 24) to 9.09, marking an increase of 1.94.
For Diluted EPS (Rs.), as of Mar 25, the value is 9.09. This value is within the healthy range. It has increased from 7.15 (Mar 24) to 9.09, marking an increase of 1.94.
For Cash EPS (Rs.), as of Mar 25, the value is 9.26. This value is within the healthy range. It has increased from 7.31 (Mar 24) to 9.26, marking an increase of 1.95.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 24.92. It has increased from 16.33 (Mar 24) to 24.92, marking an increase of 8.59.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 24.92. It has increased from 16.33 (Mar 24) to 24.92, marking an increase of 8.59.
For Dividend / Share (Rs.), as of Mar 25, the value is 1.00. This value is within the healthy range. It has increased from 0.50 (Mar 24) to 1.00, marking an increase of 0.50.
For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 83.59. It has increased from 70.85 (Mar 24) to 83.59, marking an increase of 12.74.
For PBDIT / Share (Rs.), as of Mar 25, the value is 12.41. This value is within the healthy range. It has increased from 10.11 (Mar 24) to 12.41, marking an increase of 2.30.
For PBIT / Share (Rs.), as of Mar 25, the value is 12.23. This value is within the healthy range. It has increased from 9.96 (Mar 24) to 12.23, marking an increase of 2.27.
For PBT / Share (Rs.), as of Mar 25, the value is 12.19. This value is within the healthy range. It has increased from 9.93 (Mar 24) to 12.19, marking an increase of 2.26.
For Net Profit / Share (Rs.), as of Mar 25, the value is 9.09. This value is within the healthy range. It has increased from 7.15 (Mar 24) to 9.09, marking an increase of 1.94.
For PBDIT Margin (%), as of Mar 25, the value is 14.84. This value is within the healthy range. It has increased from 14.27 (Mar 24) to 14.84, marking an increase of 0.57.
For PBIT Margin (%), as of Mar 25, the value is 14.63. This value is within the healthy range. It has increased from 14.05 (Mar 24) to 14.63, marking an increase of 0.58.
For PBT Margin (%), as of Mar 25, the value is 14.58. This value is within the healthy range. It has increased from 14.01 (Mar 24) to 14.58, marking an increase of 0.57.
For Net Profit Margin (%), as of Mar 25, the value is 10.87. This value exceeds the healthy maximum of 10. It has increased from 10.09 (Mar 24) to 10.87, marking an increase of 0.78.
For Return on Networth / Equity (%), as of Mar 25, the value is 36.46. This value is within the healthy range. It has decreased from 43.80 (Mar 24) to 36.46, marking a decrease of 7.34.
For Return on Capital Employeed (%), as of Mar 25, the value is 48.63. This value is within the healthy range. It has decreased from 60.53 (Mar 24) to 48.63, marking a decrease of 11.90.
For Return On Assets (%), as of Mar 25, the value is 25.85. This value is within the healthy range. It has decreased from 30.04 (Mar 24) to 25.85, marking a decrease of 4.19.
For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
For Asset Turnover Ratio (%), as of Mar 25, the value is 2.84. It has decreased from 3.56 (Mar 24) to 2.84, marking a decrease of 0.72.
For Current Ratio (X), as of Mar 25, the value is 1.44. This value is below the healthy minimum of 1.5. It has increased from 1.04 (Mar 24) to 1.44, marking an increase of 0.40.
For Quick Ratio (X), as of Mar 25, the value is 1.44. This value is within the healthy range. It has increased from 1.04 (Mar 24) to 1.44, marking an increase of 0.40.
For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. There is no change compared to the previous period (Mar 24) which recorded 0.00.
For Interest Coverage Ratio (X), as of Mar 25, the value is 271.82. This value is within the healthy range. It has decreased from 430.21 (Mar 24) to 271.82, marking a decrease of 158.39.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 200.07. This value is within the healthy range. It has decreased from 305.40 (Mar 24) to 200.07, marking a decrease of 105.33.
For Enterprise Value (Cr.), as of Mar 25, the value is 61.25. It has increased from 34.07 (Mar 24) to 61.25, marking an increase of 27.18.
For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.44. This value is within the healthy range. It has increased from 1.60 (Mar 24) to 2.44, marking an increase of 0.84.
For EV / EBITDA (X), as of Mar 25, the value is 16.45. This value exceeds the healthy maximum of 15. It has increased from 11.23 (Mar 24) to 16.45, marking an increase of 5.22.
For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.47. This value is within the healthy range. It has increased from 1.61 (Mar 24) to 2.47, marking an increase of 0.86.
For Price / BV (X), as of Mar 25, the value is 8.29. This value exceeds the healthy maximum of 3. It has increased from 6.98 (Mar 24) to 8.29, marking an increase of 1.31.
For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.47. This value is within the healthy range. It has increased from 1.61 (Mar 24) to 2.47, marking an increase of 0.86.
For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.04, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Crestchem Ltd as of September 15, 2025 is: 141.62

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of September 15, 2025, Crestchem Ltd is Undervalued by 7.29% compared to the current share price 132.00

Intrinsic Value of Crestchem Ltd as of September 15, 2025 is: 190.01

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of September 15, 2025, Crestchem Ltd is Undervalued by 43.95% compared to the current share price 132.00

Last 5 Year EPS CAGR: 34.17%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 23.01%, which is a positive sign. The stock has a low average Working Capital Days of -62.69, which is a positive sign. The company has shown consistent growth in sales (8.48 cr) and profit (1.01 cr) over the years.	The stock has a high average Cash Conversion Cycle of 179.74, which may not be favorable. The company has higher borrowings (0.26) compared to reserves (-1.01), which may suggest financial risk.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Crestchem Ltd:
1. Net Profit Margin: 10.87%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 48.63% (Industry Average ROCE: 14.38%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 36.46% (Industry Average ROE: 10.48%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 200.07
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.44
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 16 (Industry average Stock P/E: 58.19)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Crestchem Ltd. is a Public Limited Listed company incorporated on 26/04/1991 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24100GJ1991PLC015530 and registration number is 015530. Currently Company is involved in the business activities of Manufacture of various other chemical products(antiknock preparations, anti-freeze preparations, liquids for hydraulic transmission, composite diagnostic or laboratory reagents, writing or drawing ink, chemical substance used in manufacturing of pesticides and other chemical products). Company's Total Operating Revenue is Rs. 25.08 Cr. and Equity Capital is Rs. 3.00 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Chemicals - Organic - Others	Sr. No.550/1, Sub Plot Number 12, Mehsana Dist. Gujarat 382715	info@crestchemlimited.in http://www.crestchemlimited.in

Management
Name	Position Held
Mr. Dipak Narendraprasad Patel	Promoter, Chairman & Managing Director
Mr. Nitinkumar Shantilal Shah	Non Exe. & Ind. Director
Mrs. Rinkal Maulik Jasani	Non Exe. Women Independent Director
Mrs. Priyankaben M Patel	Ind. Non-Executive Director
Mr. Jignesh A Shah	Ind. Non-Executive Director
Mr. Nirmit Dipak Patel	Executive Director

FAQ

What is the intrinsic value of Crestchem Ltd?

Crestchem Ltd's intrinsic value (as of 15 September 2025) is 141.62 which is 7.29% higher the current market price of 132.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹39.6 Cr. market cap, FY2025-2026 high/low of 350/114, reserves of ₹4.48 Cr, and liabilities of 10.55 Cr.

What is the Market Cap of Crestchem Ltd?

The Market Cap of Crestchem Ltd is 39.6 Cr..

What is the current Stock Price of Crestchem Ltd as on 15 September 2025?

The current stock price of Crestchem Ltd as on 15 September 2025 is 132.

What is the High / Low of Crestchem Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Crestchem Ltd stocks is 350/114.

What is the Stock P/E of Crestchem Ltd?

The Stock P/E of Crestchem Ltd is 16.0.

What is the Book Value of Crestchem Ltd?

The Book Value of Crestchem Ltd is 24.9.

What is the Dividend Yield of Crestchem Ltd?

The Dividend Yield of Crestchem Ltd is 0.76 %.

What is the ROCE of Crestchem Ltd?

The ROCE of Crestchem Ltd is 59.9 %.

What is the ROE of Crestchem Ltd?

The ROE of Crestchem Ltd is 44.1 %.

What is the Face Value of Crestchem Ltd?

The Face Value of Crestchem Ltd is 10.0.